Siebert, S. and Sattar, N. (2021) Estimating cardiovascular impacts of drugs for psoriatic disease: a long way to go. Journal of Investigative Dermatology, 141(10), pp. 2322-2325. (doi: 10.1016/j.jid.2021.04.012) (PMID:34560915)
Full text not currently available from Enlighten.
Abstract
Patients with psoriasis and psoriatic arthritis are at an increased risk of cardiovascular (CV) events. A recent systematic review and meta-analysis by González Cantero et al. (2021) evaluated the effects of biologics on CV imaging and biomarkers in patients with psoriasis. In this commentary, we discuss the clinical and management implications of these and the related results for patients with psoriatic disease and the need for further pharmacoepidemiological research.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Siebert, Professor Stefan and Sattar, Professor Naveed |
| Authors: | Siebert, S., and Sattar, N. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
| Research Centre: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Immunobiology |
| Journal Name: | Journal of Investigative Dermatology |
| Publisher: | Elsevier |
| ISSN: | 0022-202X |
| ISSN (Online): | 1523-1747 |
| Published Online: | 21 September 2021 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details